rs28937890
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_006005.3(WFS1):c.2171C>T(p.Pro724Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,612,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P724S) has been classified as Pathogenic.
Frequency
Consequence
NM_006005.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WFS1 | NM_006005.3 | c.2171C>T | p.Pro724Leu | missense_variant | 8/8 | ENST00000226760.5 | NP_005996.2 | |
WFS1 | NM_001145853.1 | c.2171C>T | p.Pro724Leu | missense_variant | 8/8 | NP_001139325.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WFS1 | ENST00000226760.5 | c.2171C>T | p.Pro724Leu | missense_variant | 8/8 | 1 | NM_006005.3 | ENSP00000226760 | P2 | |
ENST00000661896.1 | n.1337+1949G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152242Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000322 AC: 8AN: 248128Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134866
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1460444Hom.: 0 Cov.: 99 AF XY: 0.0000275 AC XY: 20AN XY: 726508
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152242Hom.: 0 Cov.: 34 AF XY: 0.0000941 AC XY: 7AN XY: 74384
ClinVar
Submissions by phenotype
not provided Pathogenic:3Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | May 03, 2018 | The WFS1 c.2171C>T; p.Pro724Leu variant (rs28937890) has been previously observed as a homozygote in a pair of siblings from a consanguineous Japanese family with a Wolfram syndrome phenotype (minimally, juvenile-onset diabetes mellitus and optic atrophy; Inoue 1998). Numerous functional studies have demonstrated that this variant effects WFS1 protein stability (Hofmann 2006), localization (Fonseca 2005), increased tendency for aggregation (De Franco 2017), and interactions with ATF6 (Fonseca 2010). This variant is found in the general population with an overall allele frequency of 0.003% (8/243,604 alleles) in the Genome Aggregation Database. Based on the available information, the clinical significance of this variant cannot be determined with certainty. De Franco E et al. Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts. Diabetes. 2017 Jul;66(7):2044-2053. Fonseca SG et al. WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic beta-cells. J Biol Chem. 2005 Nov 25;280(47):39609-15 Fonseca SG et al. Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest. 2010 Mar;120(3):744-55. Hofmann S and Bauer M. Wolfram syndrome-associated mutations lead to instability and proteasomal degradation of wolframin. FEBS Lett. 2006 Jul 10;580(16):4000-4. Inoue H et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet. 1998 Oct;20(2):143-8. - |
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 04, 2020 | The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been associated with autosomal recessive Wolfram Syndrome (PMID: 9771706, 24890733) and autosomal recessive Optic Atrophy (PMID: 27395765). This variant segregates with disease in at least one family. Assessment of experimental evidence suggests this variant results in abnormal protein function. This variant abrogates the ability of WFS1 to negatively regulate ATF6-alpha, a transcription factor that is responsible for upregulating stress signaling targets, thereby causing ER-stress mediated apoptosis in pancreatic beta-cells (PMID: 20160352). In multiple individuals, this variant has been seen with a single recessive pathogenic variant in the same gene, suggesting this variant may also be pathogenic. Computational tools predict that this variant is damaging. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 11, 2023 | Published functional studies demonstrate a damaging effect resulting in abnormal ERSE reporter activity in pancreatic beta-cells (Fonseca et al., 2005; De Franco et al., 2017); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22983116, 20160352, 11709537, 11317350, 12955714, 24424032, 26435059, 16806192, 21454619, 28468959, 24227685, 27434582, 11244483, 34406036, 34848728, 37185285, 12618560, 24890733, 30245029, 9771706, 33663443, 27395765, 34404380, 36208030, 25211237, 16195229) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 27, 2021 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects WFS1 function (PMID: 16195229, 16806192). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt WFS1 protein function. ClinVar contains an entry for this variant (Variation ID: 4509). This missense change has been observed in individuals with autosomal recessive Wolfram syndrome (PMID: 9771706, 24890733). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs28937890, gnomAD 0.03%). This sequence change replaces proline, a(n) neutral and non-polar amino acid, with leucine, a(n) neutral and non-polar amino acid, at codon 724 of the WFS1 protein (p.Pro724Leu). - |
Wolfram syndrome 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 1998 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at